Gene Symbol | Ephb2 |
---|---|
Gene Name | EPH receptor B2, transcript variant X2 |
Entrez Gene ID | 101705033 |
For more information consult the page for NW_004624764.1 (Scaffold)
The following genes have been identified as possible homologs of the naked mole-rat gene and compared to it.
EPH receptor B2
Protein Percentage | 95.85% |
---|---|
CDS Percentage | 91.73% |
Ka/Ks Ratio | 0.05725 (Ka = 0.0273, Ks = 0.4761) |
EPH receptor B2
Protein Percentage | 99.9% |
---|---|
CDS Percentage | 92.63% |
Ka/Ks Ratio | 0.001 (Ka = 0.0006, Ks = 0.5847) |
Protein Percentage | 99.48% |
---|---|
CDS Percentage | 90.41% |
Ka/Ks Ratio | 0.00264 (Ka = 0.0022, Ks = 0.8317) |
Protein Percentage | 99.07% |
---|---|
CDS Percentage | 90.55% |
Ka/Ks Ratio | 0.00509 (Ka = 0.004, Ks = 0.7798) |
>XM_004850539.1 ATGGACTCCACTACTGCGACGGCTGAGCTGGGCTGGATGGTGCATCCCCCATCAGGGTGGGAAGAGGTGAGCGGCTATGACGAGAACATGAACACGATCCGCACGTACCAGGTGTGCAATGTGTTTGAGTCGAGCCAGAACAACTGGTTACGGACCAAGTTCATCCGGCGCCGTGGTGCCCACCGCATCCATGTGGAGATGAAGTTCTCAGTGCGTGACTGCAGCAGCATCCCCAGCGTGCCTGGCTCCTGCAAGGAGACCTTCAACCTCTACTACTATGAGGCTGACTTCGACTCAGCCACTAAGACCTTCCCCAACTGGATGGAGAATCCGTGGGTGAAGGTGGACACCATTGCAGCAGACGAGAGCTTCTCCCAAGTAGACCTGGGTGGCCGGGTCATGAAGATCAACACTGAGGTGCGGAGCTTTGGACCTGTGTCCCGCAGTGGCTTCTACCTGGCCTTCCAGGACTATGGTGGCTGCATGTCCCTCATTGCTGTGCGTGTCTTCTATCGAAAGTGTCCTCGCATCATCCAGAATGGTGCCATCTTCCAGGAGACACTGTCGGGGGCAGAGAGCACATCGCTGGTAGCCGCCCGGGGCAGCTGCATTGCCAACGCTGAAGAGGTGGACGTGCCCATAAAGTTGTACTGTAACGGGGACGGCGAGTGGCTGGTGCCCATCGGGCGCTGCATGTGCAAAGCAGGCTTTGAGGCTGTGGAGAATGGCACTGTCTGCCGAGGCTGCCCTTCTGGAACCTTCAAAGCCAACCAGGGGGATGAGGCCTGCACGCACTGCCCTATCAACAGCCGCACCACCTCCGAGGGAGCCACCAACTGCGTCTGCCGCAACGGCTACTACAGAGCGGACCTGGATCCCCTGGACATGCCCTGCACAACCATCCCCTCTGCCCCCCAGGCCGTGATCTCCAGCGTCAACGAGACCTCCCTGGTGCTGGAGTGGACCCCTCCCCGAGACTCTGGAGGCCGAGAGGACCTGGTCTACAACATCATCTGTAAGAGCTGCGGCTCGGGCCGGGGCGCCTGCACCCGCTGCGGCGACAACGTGCAGTATGCACCCCGCCAGCTGGGCCTGACTGAGCCACGCATCTACATCAGCGACCTGCTGGCCCACACCCAGTACACCTTTGAGATCCAGGCGGTGAATGGAGTCACCGACCAGAGCCCCTTCTCGCCACAGTTTGCCTCGGTTAACATCACCACCAACCAAGCAGCGCCATCAGCCGTATCCATCATGCATCAGGTGAGCCGCACGGTGGACAGCATCACCCTGTCATGGTCCCAGCCGGACCAGCCCAATGGTGTGATCTTGGACTATGAGCTACAGTATTATGAAAAGGAGCTCAGTGAGTACAACGCCACAGCCATAAAAAGCCCCACCAACACGGTCACTGTGCAGGGCCTCAAAGCCGGCGCCATCTATGTCTTCCAGGTGCGGGCACGCACCGTGGCAGGCTACGGGCGCTACAGCGGCAAGATGTACTTCCAGACCATGACAGAAGCCGAGTACCAGACCAGCATCCAGGAGAAGCTGCCTCTCATCATCGGCTCCTCGGCGGCCGGCCTGGTCTTCCTCATTGCTGTGGTTGTCATAGCCATTGTGTGTAACAGACGGGGGTTTGAGCGTGCCGATTCGGAGTACACAGACAAGCTGCAGCACTACACCAGTGGCCACATGACCCCAGGCATGAAGATCTACATCGACCCTTTTACCTATGAGGACCCCAACGAAGCTGTGCGGGAGTTTGCCAAGGAAATTGACATCTCCTGTGTCAAAATCGAGCAGGTGATTGGAGCAGGGGAGTTTGGCGAGGTCTGCAGTGGTCACCTGAAGCTGCCAGGCAAGAGAGAGATCTTTGTAGCCATCAAGACACTCAAGTCAGGCTACACGGAGAAGCAGCGGCGAGATTTCCTAAGCGAGGCATCCATCATGGGCCAGTTCGACCACCCCAATGTCATCCACTTGGAGGGTGTTGTCACCAAGAGCACGCCTGTGATGATCATCACCGAGTTCATGGAGAATGGCTCCCTGGACTCCTTCCTCCGGCAAAACGATGGGCAGTTCACAGTCATCCAGCTGGTGGGCATGCTGCGGGGCATCGCGGCGGGCATGAAGTATCTGGCAGACATGAACTACGTGCACCGCGACCTGGCTGCCCGCAACATCCTTGTCAACAGCAACCTGGTCTGCAAGGTGTCTGACTTTGGGCTCTCACGCTTCCTGGAGGATGACACTTCAGACCCCACCTACACCAGCGCCCTGGGGGGAAAGATCCCCATCCGCTGGACAGCTCCAGAAGCCATCCAGTACCGGAAGTTCACCTCGGCCAGTGATGTGTGGAGCTATGGTATCGTCATGTGGGAGGTGATGTCCTATGGGGAGCGGCCTTACTGGGACATGACCAACCAGGACGTAATCAATGCAATTGAGCAGGACTACAGGCTACCACCACCCATGGACTGTCCGAGTGCCCTCCACCAGCTCATGCTTGACTGCTGGCAGAAGGACCGCAACCACCGGCCCAAGTTCGGCCAGATCGTCAACACATTGGACAAGATGATCCGAAACCCCAACAGCCTCAAAGCTATGGCGCCCCTTTCCTCTGGCATCAACCTGCCGCTTTTGGACCGCACGATCCCCGACTACACCAGCTTTAACACAGTGGACGAGTGGCTGGAGGCCATCAAGATGGGGCAGTACAAGGAGAGCTTCGCCAACGCCGGCTTCACCTCCTTCGATGTCGTGTCTCAGATGATGATGGAGGACATTCTGCGGGTTGGGGTCACCTTGGCGGGCCACCAGAAAAAAATCCTGAACAGTATCCAGGTGATGAGGGCCCAGATGAACCAGATCCAGTCTGTGGAGGTTTGA
Ephb2 PREDICTED: ephrin type-B receptor 2 isoform X2 [Heterocephalus glaber]
Length: 963 aa View alignments>XP_004850596.1 MDSTTATAELGWMVHPPSGWEEVSGYDENMNTIRTYQVCNVFESSQNNWLRTKFIRRRGAHRIHVEMKFSVRDCSSIPSVPGSCKETFNLYYYEADFDSATKTFPNWMENPWVKVDTIAADESFSQVDLGGRVMKINTEVRSFGPVSRSGFYLAFQDYGGCMSLIAVRVFYRKCPRIIQNGAIFQETLSGAESTSLVAARGSCIANAEEVDVPIKLYCNGDGEWLVPIGRCMCKAGFEAVENGTVCRGCPSGTFKANQGDEACTHCPINSRTTSEGATNCVCRNGYYRADLDPLDMPCTTIPSAPQAVISSVNETSLVLEWTPPRDSGGREDLVYNIICKSCGSGRGACTRCGDNVQYAPRQLGLTEPRIYISDLLAHTQYTFEIQAVNGVTDQSPFSPQFASVNITTNQAAPSAVSIMHQVSRTVDSITLSWSQPDQPNGVILDYELQYYEKELSEYNATAIKSPTNTVTVQGLKAGAIYVFQVRARTVAGYGRYSGKMYFQTMTEAEYQTSIQEKLPLIIGSSAAGLVFLIAVVVIAIVCNRRGFERADSEYTDKLQHYTSGHMTPGMKIYIDPFTYEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMAPLSSGINLPLLDRTIPDYTSFNTVDEWLEAIKMGQYKESFANAGFTSFDVVSQMMMEDILRVGVTLAGHQKKILNSIQVMRAQMNQIQSVEV